Legal attitude: Art. 17 par. 1 MAR - confidential information.
Board of NESTMEDIC S.A. with its registered office in Wrocław (hereinafter the "Company", "Issuer"), seeking to achieve the objectives set out in the strategy of the Issuer's capital group published on May 8, 2018 in the current report of ESPI No. 14/2018, i.e. in particular in the scope of obtaining strategic partners for Polish market, especially large medical centers, informs that today it learned about the conclusion on January 28, 2019 by Medical Center Telemonitor sp. z o. o. with headquarters in Wroclaw - a subsidiary of the Issuer, (hereinafter: "Subsidiary") , contracts with the City Hospital sp. z o. o in Zabrze (hereinafter referred to as "Hospital"), (hereinafter: "Agreement").
The subject of the Agreement is the sale of Pregnabit sets for the Hospital (Pregnabit devices together with a set of probes and additional elements) along with the services provided as part of the subscription for each Pregnabit set.
The contract has been concluded for a fixed period of twenty-four (24) months, i.e. from February 1, 2019 to January 30, 2021.
The contract is payable. The remuneration of the Subsidiary for the transfer of ownership of Pregnabit sets will be paid once. However, remuneration for services provided as part of subscriptions will be billed on a monthly basis, based on a monthly lump-sum remuneration. Due to the nature of the Issuer's operations, the Issuer's Management Board considered the conclusion of the Agreement significant in the context of the income of the Issuer's capital group achieved in the last four quarters. Acquiring another large partner on the medical services market in Poland increases the possibility of promoting and implementing Issuer's products to a wider extent on the domestic market.
Source: company website, investor relations, current and periodic reports.